carbostyril has been researched along with Lymphoma, B-Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buono, R; Chiu, H; Fruman, DA; Fung, A; Herzog, LO; Jackson, MR; Lee, JS; Li, B; Mallya, S; Nguyen, N; Pinkerton, AB; Ronai, ZA; Schneider, RJ; Walters, B | 1 |
2 other study(ies) available for carbostyril and Lymphoma, B-Cell
| Article | Year |
|---|---|
Targeting eIF4F translation initiation complex with SBI-756 sensitises B lymphoma cells to venetoclax.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Proliferation; Drug Resistance, Neoplasm; Eukaryotic Initiation Factor-4E; Female; Humans; Lactams; Lymphoma, B-Cell; Mice; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Quinolones; Sulfonamides; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
48th annual meeting of the American Society of Hematology December 9-12, 2006, Orlando, FL.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Disease Progression; Drug Therapy, Combination; Hematologic Diseases; Hematology; Humans; Lenalidomide; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Melphalan; Multiple Myeloma; Prednisone; Pyrazines; Quinolones; Recurrence; Stem Cell Transplantation; Thalidomide; Transplantation Conditioning; Transplantation, Autologous | 2007 |